Martindale Pharma has many years of experience in the treatment of opioid dependence in the UK, Iceland and in Scandinavia, during which time we have worked in close collaboration with governments, leading treatment providers and healthcare professionals working in opioid dependence. It is this depth of expertise that makes us a market leader and a highly trusted supplier of medicines to treat people who are opioid dependent.
In this disease area, we are the only company with differentiated versions of each of the three molecules used to manage this important health problem. Our products provide clinically proven interventions for all stages of treatment and support.